Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Low Fat Diet and Multiple Sclerosis (MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00852722
Recruitment Status : Completed
First Posted : February 27, 2009
Last Update Posted : February 4, 2015
Information provided by (Responsible Party):
Vijayshree Yadav, Oregon Health and Science University

Brief Summary:
The purpose of this study is to evaluate if following a specific low fat diet will improve the brain damage as seen by Magnetic Resonance Imaging (MRI) and to decrease the progression of multiple sclerosis (MS) as evidenced by clinical evaluation and symptoms.

Condition or disease Intervention/treatment Phase
Multiple Sclerosis Other: Low fat study diet Phase 1

Detailed Description:
This research project has significance for its potential to develop a new therapeutic approach to MS. Current treatments in MS include disease modifying therapies such as human recombinant interferon beta, glatiramer acetate and natalizumab. However, these are only partially effective, cannot be taken orally, have side-effects and are very expensive. Developing treatment that can be combined with current disease modifying agent remains an important goal for improving the care of people with MS.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 61 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Controlled Study of Diet and Multiple Sclerosis
Study Start Date : February 2009
Actual Primary Completion Date : July 2014
Actual Study Completion Date : July 2014

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: 1. Low fat study diet
The low fat study diet arm will receive low fat diet training and followed for 12 months on the diet.
Other: Low fat study diet
The low fat study diet is a very low-saturated-fat, plant food based diet. It will be approximately 10% fat, 14% protein and 76% carbohydrate.The diet is is starched based and also contains fresh or frozen fruits and vegetables and there is no animal meat used, including no use of fish. This diet is very low in saturated fats and enriched in unsaturated fats. Subjects do not take dietary supplements.

No Intervention: 2. Regular diet group
The regular diet arm will be a wait-listed group that will receive no training in diet and will be advised to continue their regular (usual) diet as was prior to entry into the study, for the duration of the study. They will have a similar clinic follow up schedule as the treatment group. The regular diet group will be given identical instructions to exercise regularly similar to the treatment group.

Primary Outcome Measures :
  1. Number of new MS T2 lesion formation on brain MRI in those randomized to the low fat study diet with that of subjects randomized to follow their regular diet. [ Time Frame: Baseline. Month 12. ]

Secondary Outcome Measures :
  1. To assess effects of the low fat study diet on clinical activity of MS as by relapse rate and disability progression and on fatigue, depression and quality of life. [ Time Frame: Baseline. Month 3. Month 6. Month 9. Month 12. ]
  2. To study the effects of the Low Fat Study Diet on serum markers of inflammation [ Time Frame: Baseline. Month 6. Month 12. ]
  3. To assess safety and tolerability of the low fat study diet upon 12 months of administration [ Time Frame: Baseline. Month 3. Month 6. Month 9. Month 12. ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Clinical diagnosis of the relapsing-remitting form of MS
  • Age 18-70, inclusive
  • MS duration of less than 15 years
  • May or may not be on disease-modifying therapies for MS, but if on, must be on for more than 6 months of continuous therapy
  • Should not have diabetes
  • Able and willing to follow exercise instructions
  • Able and willing to travel to California for 10-day training program (cost covered by study)
  • Able and willing to travel to Portland, OR for 6 study visits over the 12 month study period (cost covered by study)

Exclusion Criteria:

  • No clinically significant MS exacerbation within 30 days of screening visit
  • No systemically administered corticosteroids within 30 days of study entry
  • Patient not pregnant or breastfeeding
  • Not taking fish oil/flax seed for at least 2 months prior to first visit
  • No other significant health programs (e.g. active coronary heart disease, liver disease, pulmonary disease) that might increase risk of patient experiencing adverse events

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00852722

Layout table for location information
United States, Oregon
Oregon Health and Science University
Portland, Oregon, United States, 97239
Sponsors and Collaborators
Oregon Health and Science University
Layout table for investigator information
Principal Investigator: Vijayshree Yadav, MD Oregon Health and Science University
Additional Information:
Layout table for additonal information
Responsible Party: Vijayshree Yadav, Principal Investigator, Oregon Health and Science University Identifier: NCT00852722    
Other Study ID Numbers: OHSU IRB00004555
First Posted: February 27, 2009    Key Record Dates
Last Update Posted: February 4, 2015
Last Verified: February 2015
Keywords provided by Vijayshree Yadav, Oregon Health and Science University:
Multiple sclerosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Multiple Sclerosis
Pathologic Processes
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases